Project Grant R01EY036222
Award Date
9/30/24
Completion Date
7/31/29
Dollars Obligated
$755K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $654,455 to The Leland Stanford Junior University to develop fair and generalizable artificial intelligence (AI) algorithms for predicting glaucoma progression. The goal is to address racial/ethnic disparities in the performance of these AI models, which disproportionately impact minority populations. The research involves comparing fairness-aware algorithm training methods, evaluating model...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $628,531 to the University of Miami to validate and implement an artificial intelligence machine-to-machine (M2M) model for equitable glaucoma screening in underserved populations. The M2M model aims to provide objective, quantitative assessments of glaucomatous damage from low-cost fundus photography, overcoming limitations of existing imaging technologies. The project will refine the M2M...
The National Eye Institute (NEI) has awarded a $466,125 Federal Project Grant (CFDA 93.867 - Vision Research) to Weill Medical College of Cornell University to develop and validate a new artificial intelligence approach to improve the fairness of predictive models for primary open-angle glaucoma (POAG) risk estimation. The project aims to study algorithmic bias in POAG risk prediction and examine the impact of transferring bias from a biased model to a demographically balanced dataset. The...
This federal Project Grant award of $715,098 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) aims to enhance glaucoma risk prediction through advanced genomics and machine learning. The key products and services to be delivered include: Improving polygenic risk score (PRS) performance for glaucoma by leveraging natural language processing techniques and electronic health record data from over 68,000 patients to extract refined glaucoma phenotypes. The...
Aisight Health Inc. received a $479,580 Project Grant award from the National Institutes of Health's National Eye Institute to develop artificial intelligence tools to identify rapid glaucoma progression. The goal is to use machine learning models trained on over a decade of optical coherence tomography images, visual field tests, and clinical records for more than 9,000 glaucoma patients to more accurately and quickly determine which patients are likely to experience rapid vision loss from...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $617,201 in funding to Emory University to conduct research aimed at improving the understanding and management of glaucoma, a leading cause of blindness. The key research objectives are to: 1) Map the 3D paths of optic nerve axons using optical coherence tomography (OCT) imaging; 2) Leverage AI to assess whether axonal deformations could serve as diagnostic and prognostic biomarkers for...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $450,002.00 to The Trustees of the University of Pennsylvania to develop robust and equitable clinical decision support systems for glaucoma detection and progression prediction. The project will run from September 1, 2024 to August 31, 2028. The University of Pennsylvania, a leading academic medical center, will leverage its expertise in biomedical research and healthcare...
This $433,841 federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports the development of computational methods and deep learning models to analyze imaging data and identify biomarkers for age-related macular degeneration (AMD). The goal is to improve understanding of AMD disease progression and response to treatment. Specifically, the project will develop deep neural network models to analyze optical coherence tomography,...
This Project Grant award of $1,593,473.00, provided by the National Eye Institute under the Vision Research program (CFDA 93.867), will support a multiomic analysis of preclinical biomarkers for primary open-angle glaucoma (POAG). The study aims to analyze proteomic and metabolomic markers, and their interactions with genetic predisposition, to advance understanding of POAG pathophysiology. Researchers will use plasma samples from a nested case-control group within ongoing prospective cohorts,...
This Project Grant award of $437,959 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to develop, evaluate, and validate large language models (LLMs) for studying amblyopia treatment, adherence, and outcomes using electronic health record (EHR) data. The project aims to enable more research and the development of clinical decision support tools that leverage data from EHR clinical notes, which often contain inconsistent documentation of...